Related Experiment Videos
Gadolinium-DTPA in spinal disease
1Department of Radiology, Cornell University Medical College, New York, New York.
Radiologic Clinics of North America
|September 1, 1988
Summary
Gadolinium-DTPA contrast agents show promise for spine MRI evaluations. Careful application is needed due to unique spinal lesion enhancement patterns, especially for extradural disease.
Area of Science:
- Radiology
- Medical Imaging
- Neurology
Background:
- Magnetic Resonance (MR) imaging is crucial for spinal evaluations.
- Paramagnetic contrast agents, like gadolinium-DTPA, enhance MR imaging.
- Specific models for contrast enhancement in the spine are limited.
Purpose of the Study:
- To evaluate the utility of gadolinium-DTPA in MR imaging of the spine.
- To understand the enhancement patterns of spinal lesions.
- To define appropriate clinical applications for contrast use in spinal MR.
Main Methods:
- Review of clinical applications and imaging findings.
- Analysis of contrast enhancement in various spinal pathologies.
- Comparison of gadolinium-DTPA efficacy in different lesion types.
Main Results:
- Gadolinium-DTPA is highly effective for intradural extramedullary and intramedullary diseases.
- Enhancement patterns in spinal lesions exhibit unique characteristics.
- Use in extradural disease requires careful consideration of specific clinical scenarios.
Conclusions:
- Gadolinium-DTPA is a valuable tool for specific spinal MR applications.
- Understanding lesion-specific enhancement is key to optimal contrast use.
- Further research may refine guidelines for contrast administration in spinal MR.